Kari Wisinski, Professor, Chief of Hematology, Medical Oncology and Palliative Care

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Pfizer
    Topic:
    IIT support through BTCRC
    Date added:
    05/29/2024
    Date updated:
    05/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Pfizer
    Topic:
    Advisory board
    Date added:
    05/29/2024
    Date updated:
    05/29/2024
    Relationship end date:
    12/05/2022
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Pfizer
    Topic:
    site PI for clinical trial
    Date added:
    05/29/2024
    Date updated:
    05/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Novartis
    Topic:
    IIT support
    Date added:
    05/29/2024
    Date updated:
    05/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Novartis
    Topic:
    Site PI for clinical trial
    Date added:
    05/29/2024
    Date updated:
    05/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Stemline
    Topic:
    Advisory board
    Date added:
    05/29/2024
    Date updated:
    05/29/2024
    Relationship end date:
    05/30/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Gilead
    Topic:
    Advisory Board
    Date added:
    05/29/2024
    Date updated:
    05/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Seagen
    Topic:
    Advisory board
    Date added:
    05/29/2024
    Date updated:
    05/29/2024
    Relationship end date:
    01/24/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    LoxoLilly
    Topic:
    Advisory Board
    Date added:
    05/29/2024
    Date updated:
    05/29/2024
    Relationship end date:
    09/21/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    AstraZeneca
    Topic:
    Advisory Board
    Date added:
    05/29/2024
    Date updated:
    05/29/2024
    Relationship end date:
    12/01/2023

Pages

Return to Best of ASCO 2024, Milwaukee